Investigation of binding mechanism for newly synthesized apigenin derivatives with xanthine oxidase: spectroscopic and computational approach

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Journal of Molecular Structure

• Publication date

  2025-03-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/j.molstruc.2025.142112
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Evaluation of anti-hyperuricemic and nephroprotective activities and discovery of new XOD inhibitors of Morus alba L. root bark.

  2025cited by this paper
• Cardiovascular safety of febuxostat and allopurinol in patients with gout: A meta-analysis

  2022cited by this paper
• Apigenin Ameliorates Hyperuricemia and Renal Injury through Regulation of Uric Acid Metabolism and JAK2/STAT3 Signaling Pathway

  2022cited by this paper
• Discovery of a Novel Series of Imipridone Compounds as Homo sapiens Caseinolytic Protease P Agonists with Potent Antitumor Activities In Vitro and In Vivo.

  2022cited by this paper
• Chalcone derivatives as xanthine oxidase inhibitors: synthesis, binding mode investigation, biological evaluation, and ADMET prediction.

  2022cited by this paper
• Investigation of the interaction between Chrysoeriol and xanthine oxidase using computational and in vitro approaches.

  2021cited by this paper
• Isorhamnetin, the xanthine oxidase inhibitor from Sophora japonica, ameliorates uric acid levels and renal function in hyperuricemic mice.

  2021cited by this paper
• Interaction mechanism of flavonoids with whey protein isolate: A spectrofluorometric and theoretical investigation.

  2021cited by this paper
• The Key Role of Uric Acid in Oxidative Stress, Inflammation, Fibrosis, Apoptosis, and Immunity in the Pathogenesis of Atrial Fibrillation

  2021cited by this paper
• Comparative effects of quercetin, luteolin, apigenin and their related polyphenols on uric acid production in cultured hepatocytes and suppression of purine bodies‐induced hyperuricemia by rutin in mice

  2021cited by this paper
• Hyperuricemia As a trigger of Immune Response in Hypertension and Chronic Kidney Disease.

  2020cited by this paper
• Interaction mechanism of flavonoids on bovine serum albumin: Insights from molecular property-binding affinity relationship.

  2020cited by this paper
• Multi-spectroscopic investigation, molecular docking and molecular dynamic simulation of competitive interactions between flavonoids (quercetin and rutin) and sorafenib for binding to human serum albumin.

  2020cited by this paper
• Screening of key flavonoids and monoterpenoids for xanthine oxidase inhibitory activity-oriented quality control of Chrysanthemum morifolium Ramat. 'Boju' based on spectrum-effect relationship coupled with UPLC-TOF-MS and HS-SPME-GC/MS.

  2020cited by this paper
• Natural Products and Extracts as Xantine Oxidase Inhibitors - A Hope for Gout Disease?

  2020cited by this paper
• In Vitro Cytotoxicity and Interaction of Noscapine with Human Serum Albumin: Effect on Structure and Esterase Activity of HSA.

  2019cited by this paper
• Targeting the subpocket in xanthine oxidase: Design, synthesis, and biological evaluation of 2-[4-alkoxy-3-(1H-tetrazol-1-yl) phenyl]-6-oxo-1,6-dihydropyrimidine-5-carboxylic acid derivatives.

  2019cited by this paper
• Five individual polyphenols as tyrosinase inhibitors: Inhibitory activity, synergistic effect, action mechanism, and molecular docking.

  2019cited by this paper
• Identification of the Uric Acid Thresholds Predicting an Increased Total and Cardiovascular Mortality Over 20 Years

  2019cited by this paper
• The impact of xanthine oxidase (XO) on hemolytic diseases

  2018cited by this paper
• Physiology of Hyperuricemia and Urate-Lowering Treatments

  2018cited by this paper
• Novel uricosurics

  2018cited by this paper
• Design, synthesis and biological evaluation of novel xanthine oxidase inhibitors bearing a 2-arylbenzo[b]furan scaffold.

  2018cited by this paper
• Febuxostat for the treatment of hyperuricaemia in gout

  2018cited by this paper
• Development of Nephrolithiasis in Asymptomatic Hyperuricemia: A Cohort Study.

  2017cited by this paper
• Hyperuricemia and clustering of cardiovascular risk factors in the Chinese adult population

  2017cited by this paper
• Interplay of multiple interaction forces: Binding of tyrosine kinase inhibitor nintedanib with human serum albumin.

  2016cited by this paper
• Xanthine dehydrogenase: An old enzyme with new knowledge and prospects

  2016cited by this paper
• Effect of Soy Sauce on Serum Uric Acid Levels in Hyperuricemic Rats and Identification of Flazin as a Potent Xanthine Oxidase Inhibitor.

  2016cited by this paper
• Hyperuricemia-Related Diseases and Xanthine Oxidoreductase (XOR) Inhibitors: An Overview

  2016cited by this paper
• Heparin makes differences: a molecular dynamics simulation study on the human βII-tryptase monomer.

  2015cited by this paper
• Reperfusion injury and reactive oxygen species: The evolution of a concept☆

  2015cited by this paper
• Safety of allopurinol compared with other urate-lowering drugs in patients with gout: a systematic review and meta-analysis

  2015cited by this paper
• Discovery of xanthine oxidase inhibitors and/or α-glucosidase inhibitors by carboxyalkyl derivatization based on the flavonoid of apigenin.

  2015cited by this paper
• X-ray crystal structure of a xanthine oxidase complex with the flavonoid inhibitor quercetin.

  2014cited by this paper
• Substrate orientation and specificity in xanthine oxidase: crystal structures of the enzyme in complex with indole-3-acetaldehyde and guanine.

  2014cited by this paper
• A review of methods available to estimate solvent-accessible surface areas of soluble proteins in the folded and unfolded states.

  2014cited by this paper
• Hyperuricemia and Risk of Incident Hypertension: A Systematic Review and Meta-Analysis of Observational Studies

  2014cited by this paper
• Inhibitory effect of morin on tyrosinase: insights from spectroscopic and molecular docking studies.

  2014cited by this paper
• Hyperuricaemia and gout: time for a new staging system?

  2014cited by this paper
• Interaction of an amino-functionalized ionic liquid with enzymes: a fluorescence spectroscopy study.

  2013cited by this paper
• 2012 American College of Rheumatology guidelines for management of gout. Part 2: Therapy and antiinflammatory prophylaxis of acute gouty arthritis

  2012cited by this paper
• Hyperuricemia and coronary heart disease: A systematic review and meta‐analysis

  2010cited by this paper
• Acute, food-induced moderate elevation of plasma uric acid protects against hyperoxia-induced oxidative stress and increase in arterial stiffness in healthy humans.

  2009cited by this paper
• Febuxostat: a new treatment for hyperuricaemia in gout.

  2009cited by this paper
• PEG-uricase in the management of treatment-resistant gout and hyperuricemia.

  2008cited by this paper
• Hypouricemic action of selected flavonoids in mice: structure-activity relationships.

  2007cited by this paper
• Apigenin and cancer chemoprevention: progress, potential and promise (review).

  2007cited by this paper
• The fluorescence resonance energy transfer (FRET) gate: a time-resolved study.

  2005cited by this paper
• Flavonoids: a review of probable mechanisms of action and potential applications.

  2001cited by this paper
• Crystal structures of bovine milk xanthine dehydrogenase and xanthine oxidase: structure-based mechanism of conversion.

  2000cited by this paper

• No citing papers are available for this paper.